ehealth radio network
Citius Pharmaceuticals, dedicated to the development and commercialization of critical care products

Citius Pharmaceuticals, dedicated to the development and commercialization of critical care products

December 5, 2020

 

Citius_Pharma_Feature-27ir8u.png

Myron Holubiak, President and CEO of Citius Pharmaceuticals, and Leonard Mazur, Chairman of the Board at Citius Pharmaceuticals, a specialty late-stage pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infectives and cancer care joins eHealth Radio and the Cancer Information and Health News Channels.


Listen to interview with host Eric Michaels and guests Myron Holubiak & Leonard Mazur discuss the following:

  1. Please give us an overview of catheter-related bloodstream infections (CRBSIs) and central venous catheters (CVCs).
  2. Who is at Risk for Catheter-Related Bloodstream Infections (CRBSIs)?
  3. Please give us a brief description of Minolok and how does it help the standard of care in the management of CRBSIs?
  4. Give us a brief description of our NoveCite subsidiary and the impact of Covid 19 patients w ARDS. What is your technology and why is it different?
  5. How is the development of MinoWrap for mastectomies progressing after your collaboration w MD Andersen?
  6. Why did the both of you invest 26.5 million into the company?

Mr. Mazur is an accomplished entrepreneur and pharmaceutical industry executive with notable accomplishments in founding, building and creating value and returns for investors. Mr. Mazur was the Chairman of Leonard Meron Biosciences, Inc. prior to its merger with Citius in March 2016. He is the cofounder and Vice Chairman of Akrimax Pharmaceuticals, LLC (“Akrimax”), a privately held pharmaceutical company specializing in producing cardiovascular and general pharmaceutical products. Akrimax was founded in September 2008, and has successfully launched prescription drugs while acquiring drugs from major pharmaceutical companies. From January 2005 to May 2012, Mr. Mazur also co-founded and served as the Chief Operating Officer of Triax Pharmaceuticals LLC (“Triax”), a specialty pharmaceutical company producing prescription dermatological drugs. Prior to joining Triax, he was the founder, and, from 1995 to 2005, Chief Executive Officer, of Genesis Pharmaceuticals, Inc. (“Genesis”), a dermatological products company that marketed its products through dermatologists’ offices, and co-promoted products for major pharmaceutical companies. In 2003, Mr. Mazur successfully sold Genesis to Pierre Fabre, a leading pharmaceutical company.

Mr. Mazur has extensive sales, marketing and business development experience from his tenures at Medicis Pharmaceutical Corporation, as Executive Vice President, ICN Pharmaceuticals, Inc., as Vice President, Sales & Marketing, Knoll Pharma (a division of BASF), and Cooper Laboratories, Inc.

Mr. Mazur is a member of the Board of Trustees of Manor College, and is a recipient of the Ellis Island Medal of Honor. Mr. Mazur received both his BA and MBA from Temple University, and has served in the US Marine Corps Reserves.


Mr. Holubiak has extensive experience in managing and leading both large and emerging pharmaceutical and life sciences companies. Mr. Holubiak was co-founder, director and CEO of Leonard Meron Biosciences, Inc. prior to its merger with Citius in March 2016. Mr. Holubiak was the President of Roche Laboratories, Inc. (“Roche”), a major research-based pharmaceutical company, from December 1998 to August 2001.

Prior to that, he held sales and marketing positions at Roche during his 19-year tenure there. As President of Roche, Mr. Holubiak helped transform Roche Labs into a leading antibiotic and biotechnology company. He was also founder of Emron, Inc., a health economics and managed care consulting company, and helped to create the Academy of Managed Care Pharmacy (AMCP). Mr. Holubiak was also a director of Bioscrip, Inc., a national home infusion company, from 2002 through 2016, and served as its Chairman of the Board from 2012 through 2016.

Since July 2010, Mr. Holubiak has served as a member of the Board of Directors of Assembly Biosciences, Inc. (“Assembly”) and its predecessor, Ventrus Biosciences, Inc. Mr. Holubiak is also a trustee of the Academy of Managed Care Pharmacy Foundation. He received a BS in Molecular Biology and Biophysics from the University of Pittsburgh; he received advanced business training from the Harvard Business School and the University of London, as well as advanced training in health economics from the University of York’s Centre for Health Economics.

 

300_colorCITIUS-PHARMA-LOGO-WIDE.png

 

Website: citiuspharma.com

How the COVID-19 Pandemic is Worsening the Opioid Crisis

How the COVID-19 Pandemic is Worsening the Opioid Crisis

December 4, 2020

 

Dr_Joseph_DeSanto8jg2s.png

 

Dr. Joseph DeSanto, an Addiction Specialist with BioCorRx Inc., an addiction treatment solutions company targeting substance use and other related disorders joins eHealth Radio and the Addiction Prevention and Health News Channels.


Listen to interview with host Eric Michaels and guest Dr. Joseph DeSanto discuss the following:

  1. How has COVID-19 exasperated the US opioid crisis?
  2. What added factors may cause addicts to relapse during the pandemic?
  3. How has telehealth helped serve the addiction recovery community? Can you tell me how BioCorRx uses telehealth?
  4. What makes the Beat Addiction Recovery Program unique?
  5. With the winter holidays approaching, why are addicts more likely to relapse?
  6. How can family members help loved ones get help and navigate their addiction during these unprecedented times?

Dr. Joseph DeSanto is a Board Certified Addictionologist for DeSanto Clinics and addiction specialist with addiction treatment solutions company, BioCorRx. He has more than 12 years of experience practicing medicine, is a graduate of Lafayette College and attended the State University of New York at Downstate in Brooklyn for his medical school training. He completed his internship and residency training at Cedars Sinai Medical Center in Los Angeles and is Board Certified by the American Board of Internal Medicine. In addition to his role with BioCorRx, he serves as a medical consultant for a number of treatment centers in Orange County, CA.

 

Beat_Addiction_Recovery_FinalTransparent_LOGO95kym.png

Website: BeatAddiction.com

Social Media Links:
Twitter: twitter.com/biocorrxinc 
Facebook: facebook.com/BioCorRx

CEO of Ready, Set, Food! Talks About Allergy Prevention For Babies!

CEO of Ready, Set, Food! Talks About Allergy Prevention For Babies!

December 3, 2020

 

Daniel_Zakowski85egn.jpeg

 

Daniel Zakowski, the CEO and co-founder at Ready, Set, Food! - an innovative company that is working to help prevent babies from developing severe food allergies joins eHealth Radio and the Allergy Information & Health News Channels. Daniel even was on the hit show Shark Tank, where he got investor Mark Cuban to join the RSF team!


Listen to interview with host Eric Michaels and guest Daniel Zakowski discuss the following:

  1. How did you come up with the Ready, Set, Food! product and concept?
  2. What are the health benefits to kids taking it daily?
  3. What is the recommended daily dosage?
  4. For parents that may be worried about adding this to their infants bottles, what have the results been like?
  5. Your product is partnering with hospitals and organizations around the US. Tell us more about what's to come!

 

RSF-with-Peanut-Egg-and-Milk.png

 

Ready, Set, Food! is the first to introduce a system that is safe and easy for parents to gently introduce products to babies via powder packets that get added to a baby's bottle or food. The company has already helped reduce the risk of food allergies in kids by 80% and helped prevent over 200,000 babies across the US from developing those severe food allergies.

 

31491689_747510058972377_1372737484537403193_n.png

 

Website: readysetfood.com

Social Media Links:
Instagram: instagram.com/readysetfood 
Facebook: facebook.com/readysetfood

COVID-19 and Mental Health Issues: The Changing Picture

COVID-19 and Mental Health Issues: The Changing Picture

December 2, 2020

 

JasonLevine_Professional9fnbu.jpg

 

Dr. Jason Levine, Clinical Psychologist in private practice in Los Angeles that specializes in Substance Use Disorders, Anxiety, Depression, LGBTQ+ issues, and anger management joins eHealth Radio and the Mental Health & Health News Channels.


Listen to interview with host Eric Michaels and guest Dr. Jason Levine discuss the following:

  1. How has the pandemic impacted people with previous mental health or substance abuse challenges?
  2. What are some things people can do to lessen their anxiety or depression?
  3. What is the CBT Model of treatment?
  4. What do you see as challenges ahead as the pandemic numbers increase and there is uncertainty around when things will get better?
  5. How can loved ones get involved if they see issues developing with someone in their family?

 

eu_natural_breathe_ads_300x250_8_part_17jx5e.jpg

 

Dr. Levine is a licensed Clinical Psychologist born, raised, and clinically trained in New York. He has held a number of leadership positions throughout the years and is currently in private practice in Los Angeles, CA. His most recent position was as Senior Executive Director of Promises Treatment Centers in Malibu.

Dr. Levine offers expert treatment for those who seek a caring and highly experienced treatment provider. He offers highly individualized cognitive behavioral and psychodynamic treatment in his specialty areas of substance use, anxiety and depression, LGBTQ+, persons with HIV/AIDS, anger management and smoking cessation treatment. Dr. Levine has been trained at the Mayo Clinic in their Tobacco Specialist Training Program to provide expert vaping, chew and smoking cessation services.

Dr. Levine received his doctorate from the New School for Social Research in New York City and has since been providing clinical treatment and administrative oversight to a myriad of cutting-edge programs for over 25 years. Dr. Levine has always made it his priority to implement the most innovative treatment solutions for the most challenging issues.

Dr. Levine can be reached at: levinephd@gmail.com.

 

Levine_Psychological_Logo71k04.png

 

Website: www.jasonlevinephd.com

Social Media Links:
Instagram: instagram.com/levinephd 
Facebook: facebook.com/jasonlevinepsychologist


The beliefs, views, ideas, thoughts and opinions expressed on any program are those of the persons appearing on the program and do not necessarily reflect the views and opinions of the eHealth Radio Network.

Podbean App

Play this podcast on Podbean App